# Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy

> **NCT07390071** · NA · RECRUITING · sponsor: **University of Utah** · enrollment: 40 (estimated)

## Conditions studied

- Lymphoma
- Myeloma
- Cytokine Release Syndrome
- Immune Effector Cell Associated Neurotoxicity Syndrome

## Interventions

- **DEVICE:** Home Automated Telemanagement (HAT) Patient Unit

## Key facts

- **NCT ID:** NCT07390071
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2029-01
- **Final completion:** 2029-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07390071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07390071, "Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT07390071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*